Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to assess the safety and efficacy of CORT113176 (dazucorilant) in patients with Amyotrophic Lateral Sclerosis (ALS).
Epistemonikos ID: 4c6db21c148d87c2e096cd95f50d93941f010427
First added on: May 13, 2024